Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACP6 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | LAD1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
mRNA | CTIF | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | MTOR | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | SEPHS1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | MT-CO1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | PCDH1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | TRAIP | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | ANOS1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | FBXO15 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |